Docstoc

FENU-SANDRO-PUBBL

Document Sample
FENU-SANDRO-PUBBL Powered By Docstoc
					                                    Pubblicazioni Scientifiche
                                      del Dr. Sandro Fenu

1. M. MORELLI, S. FENU, G. DI CHIARA: Behavioural expression of D1 receptor supersensitivity depends
    on previous stimulation of D2 receptors. Life Science, Vol 40, pp 245-251, 1987 “Citation index” 12
2. M. MORELLI, S. FENU, G. DI CHIARA: Priming" of the expression of dopamine D-1 receptor
    supersensitivity: Beavioural and neurochemical studies Pharmacological Research Communications
    Volume 20, Issue SUPPL. 2, September 1988, Page 255
3. M. MORELLI, S. FENU, G. POMATA, G. DI CHIARA: “Priming” phenomena in the expression of D1 and
    D2 receptor supersensitivity. In “Pharmacology and functional regulation of dopaminergic
    neurons”, edited by P.M. Beart, G.N. Woodruff and D.M. Jackson Mac Millan, England, 1988
4. M. MORELLI, S. FENU, L. GARAU, G. DI CHIARA: Time and dose dependence of the “priming” of the
    expression of dopamine receptor supersensitivity. Eur. J. Pharmacol., Vol 162, pp. 329-335, 1989.
    “Citation index” 48
5. M. MORELLI, S. FENU, G. DI CHIARA: Substantia nigra as a site of origin of dopaminergic dependent
    motor syndromes induced by stimulation of µ and δ opioid receptors. Brain Research, Vol 487, pp
    120-130, 1989. “Citation index” 21
6. M. MORELLI, S. FENU, A. COZZOLINO, G. DI CHIARA: The influence of priming on the behavioral
    expression of dopamine receptor supersensitivity in basal ganglia. In “Basic, clinical and
    therapeutic aspects of Alzheimer’s and Parkinson’s diseases”, Vol I, edited by Nagatsu et al.
    Plenum Press, New York, 1990.
7. M. MORELLI, G. DE MONTIS, S. FENU, A. COZZOLINO, G. DI CHIARA: Priming of the behavioral of
    dopamine-receptor supersensitivity in the basal ganglia: pharmacological and biochemical studies.
    In “The basal ganglia III”, edited by G. Bernardi et al. Plenum Press, New York, 1990.
8. M. MORELLI, S. FENU, A. COZZOLINO, G. DI CHIARA: Positive and negative interactions in the
    behavioural expression of D1 and D2 receptor stimulation in a model of parkinsonism: role of
    priming. Neuroscience, Vol 42 No 1, pp 41-48, 1991. “Citation index” 6
9. M. MORELLI, S. FENU, A. PINNA, A. COZZOLINO, G. DI CHIARA: Blockade of NMDA receptors
    differentially affects D1 and D2 mediated turning behavior in the 6-hydroxydopamine model of
    Parkinson. Amino Acids, Vol 1, pp 205-213, 1991.
10. M. MORELLI, S. FENU, G. DI CHIARA: Blockade of n-methyl-d-aspartate receptors potentiates
    dopaminergic responses in the 6-ohda model of parkinson: differential role of D1 and D2 receptors.
    Neurochem. Int., 20 Suppl., pp 261-264, 1992. “Citation index” 12
11. M. MORELLI., S. FENU, A. PINNA, G. DI CHIARA: Opposite effects of NMDA receptor blockade on
    dopaminergic D1 and D2-mediated behavior in the 6-hydroxydopamine model of turning:
    relationship with c-fos expression. J. Pharmacol. Exp. Therap.,Vol 260, pp 402-408, 1992. “Citation
    index” 80
12. M. MORELLI, S. FENU, A. COZZOLINO, A. PINNA, A. CARTA AND G. DI CHIARA: Blockade of
    muscarinic receptors potentiated D1 dependent turning behavior and c-fos expression in 6-
    hydroxydopamine lesioned rats while does not influence D2 mediated responses. Neuroscience, Vol.
    53, N° 3, pp 673-678, 1993. “Citation index” 26
13. MORELLI, A. COZZOLINO, A. PINNA, S. FENU, A. CARTA AND G. DI CHIARA: L-Dopa stimulates in
    dopamine denervated striatum by combined activation of D1 and D2 receptors. Brain Research, Vol
    623, pp 334-336, 1993. “Citation index” 33
14. MORELLI, S. FENU, A. PINNA, A. COZZOLINO, A. CARTA AND G. DI CHIARA: "Priming" to dopamine
    agonist-induced contralateral turning as a model of non-associative sensitization to the expression
    of the post-synaptic dopamine message. Behav. Pharmacology, Vol 4, pp 389-397, 1993. “Citation
    index” 21
15. MORELLI, S. FENU A. PINNA AND G. DI CHIARA: Adenosine A2 Receptors interact negatively with
    dopamine D1 and D2 receptors in unilaterally 6-hydroxydopamine-lesioned rats. Eur. J.
    Pharmacology,Vol 251, pp 21-25, 1994. “Citation index” 83
16. M. MORELLI, A. PINNA, S. FENU, A. CARTA, A. COZZOLINO AND G. DI CHIARA: Differential effect of
    MK 801 and scopolamine on c-fos expression induced by L-Dopa in the striatum of 6-
    hydroxydopamine lesioned rats. Synapse, Vol 18, pp 288-293, 1994. “Citation index” 19
17. S. FENU, A. CARTA AND M. MORELLI: Modulation of dopamine d1-mediated turning behavior and
    striatal c-fos expression by the substantia nigra. Synapse, Vol 19, pp 233-240, 1995. “Citation
    index” 22
18. S. FENU, A. CARTA AND M. MORELLI: Intranigral injections of glutamate antagonists modulate
    dopamine d1-mediated turning behavior and striatal c-fos expression. J. Neural. Transm., Vol 45, pp
    75-81, 1995. “Citation index” 5
19. M. MORELLI, S. FENU, A. CARTA AND G. DI CHIARA: Effect of MK 801 on priming of D1-dependent
    contralateral turning and its relationship to c-fos expression in the rat caudate-putamen. Behav.
    Brain Research. Vol 79, pp 93-100, 1996. “Citation index” 14
20. FENU, A. PINNA, E. ONGINI, M. MORELLI: Adenosine A2A receptor antagonism potentiates L-Dopa-
    induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats. Eur. J. Pharm.
    Vol 321, pp 143-147, 1997. “Citation index” 104
21. FENU, M. MORELLI: Motor stimulants effects of caffeine in 6-hydroxydopamine lesioned rats are
    dependent on previous stimulation of dopamine receptors: different role of D1 and D2 receptors. Eur.
    J. Neuroscience Vol 10, pp 1878-1884, 1998. “Citation index” 31
22. M. MORELLI, S. FENU : Role of dopamine receptors in the induction and expression of rotational
    behavior induced by caffeine in 6-hydroxydopamine-lesioned rats. Drug Development Research, Vol
    45, pp 373-378, 1998. “Citation index” 5
23. E. ACQUAS, S. FENU, P. LODDO, G. DI CHIARA: A within-subjects microdialysis-behavioural study of the
    role of striatal acetylcholine in D1-dependent turning. Behavioral Brain Research Vol 103, pp 219-228,
    1999. “Citation index” 3
24. G. DI CHIARA, G. TANDA, V. BASSAREO, F. PONTIERI, E. ACQUAS, S. FENU, C. CADONI, E. CARBONI:
    Drug addiction as a disorder of associative learning: role of nucleus accumbens shell/extended
    amygdala dopamine. Annals of the New York Academy of Sciences, Vol 877, pp 461-485, 1999.
    “Citation index” 84
25. S. FENU, O. CAULI, M. MORELLI: Cross-sensitization between the motor activating effects of
    bromocriptine and caffeine: role of adenosine A2A receptors. Behav. Brain Research, Vol 114, pp 97-
    105, 2000. “Citation index” 21
26. A PINNA, S. FENU, M. MORELLI: Motor stimulant effects of the adenosine A2A receptor antagonist
    SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats.
    Synapse, Vol: 39, pp 233-238, 2001. “Citation index” 65
27. CARTA, S. FENU, M. MORELLI: Alterations on GAD67, dynorphin and enkephalin mrna in striatal
    output neurons following priming in the 6-ohda model of parkinson’s disease. Neurological
    Sciences, Vol 22 (1), pp 59-60, 2001. “Citation index” 11
28. S. FENU, E. ACQUAS, G. DI CHIARA: Role of acetylcholine on dopamine D1 receptor agonist-induced
    turning behaviour in 6-hydroxydopamine lesioned rats: a microdialysis/behavioural study.
    Neurological Sciences, Vol 22 (1), pp 63-64, 2001. “Citation index” 3
29. S. FENU, V. BASSAREO, G. DI CHIARA: A role for dopamine D1 receptors of the nucleus accumbens
    shell in conditioned taste aversion. Journal of Neuroscience, Vol 21(17), pp 6897-6904, 2001.
    “Citation index” 64
30. S. FENU, G. DI CHIARA : Facilitation of conditioned taste aversion learning by systemic
    amphatamine: role of nucleus accumbens shell dopamine D1 receptors. European J Neuroscience,
    Vol 18, pp 2025-2039, 2003. “Citation index” 28
31. A.R. CARTA, S. FENU, P. PALA, E. TRONCI, M. MORELLI: Selective modifications in GAD67 mrna levels
    in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-
    hydroxydopamine-lesioned rats. European J Neuroscience, Vol 18, pp 2563-2572, 2003. “Citation
    index” 14
32. N. SIMOLA, S. FENU, P.G. BARALDI, M.A. TABRIZI, M. MORELLI: Blockade of adenosine A2A receptors
    antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions.
    Experimental Neurology; 189(1):182-8, 2004. “Citation index” 37
33. G. DI CHIARA, V. BASSAREO, S. FENU, M. A. DE LUCA, L. SPINA, C. CADONI, E. ACQUAS, E. CARBONI,
    V. VALENTINI, D. LECCA: Dopamine and drug addiction: the nucleus accumbens shell connection.
    Neuropharmacology; 47 Suppl 1:227-41, 2004. “Citation index” 244
34. S. FENU, E. RIVAS, G. DI CHIARA: Differential role of dopamine in drug- and lithium conditioned
    saccharin avoidance. Physiology & Behaviour 85(1):37-43, 2005. “Citation index” 5
35. L. SPINA, S. FENU, R. LONGONI, E. RIVAS, G. DI CHIARA: Nicotine-conditioned single trial place
    preference: selective role of nucleus accumbens shell dopamine D1 receptors in acquisition.
    Psychopharmacology 184(3-4): 447-55, 2006. “Citation index” 34
36. PISANU A, E. ACQUAS, S. FENU, G. DI CHIARA: Modulation of Δ9-THC-induced increase of cortical
    and hippocampal acetylcholine release by µ opioid and D1 dopamine receptors.
    Neuropharmacology, May; 50(6):661-70, 2006. “Citation index” 15
37. S. FENU, L. SPINA, E. RIVAS, R. LONGONI, G. DI CHIARA: Morphine-conditioned single-trial place
    preference: role of nucleus accumbens shell dopamine receptors in acquisition.
    Psychopharmacology Aug;187(2):143-53, 2006. “Citation index” 30
38. N. SIMOLA, S. FENU, P.G. BARALDI, M.A. TABRIZI, M. MORELLI: Dopamine and adenosine receptor
    as basis for the treatment of parkinson’s disease. J Neurol Sci, Oct 25;248(1-2):48-52, 2006.
    “Citation index” 4
39. SIMOLA N, FENU S, BARALDI PG, TABRIZI MA, MORELLI M. Involvement of globus pallidus in the
    antiparkinsonian effects of adenosine A2A receptor antagonists. Exp Neurol, Nov;202(1):255-7,
    2006 “Citation index” 12
40. E. RIVAS, S. FENU, MA. DE LUCA, V. BASSAREO, JA FONTENLA AND G. DI CHIARA: Effects of QO-IIR, a
    new COMT inhibitor, in experimental animal models of parkinson’s disease: behavioural,
    neurochemical and immunoistochemical study. In “Monitoring Molecules in Neuroscience”
    proceeding of the 11th International Conference on in Vivo Methods, 2006
41. BASSAREO V., DEVOTO P., FENU S., VALENTINI V. Dopamina: cinquant’anni, ma non li dimostra.
    Medicina delle Tossicodipendenze, Italian Journal of the Addictions, 57: 63-65, 2007.
42. SIMOLA N, FENU S, BARALDI PG, TABRIZI MA, MORELLI M. Blockade of globus pallidus adenosine
    A2A receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D1
    or D2 dopamine receptor agonists . Synapse 62: 345-351, 2008. “Citation index” 3
43. FENU S., E. RIVAS, G. DI CHIARA: Differential involvement of dopamine D1 receptors in morphine-
    and lithium- conditioned saccharin avoidance. Physiology & Behaviour 96(1):73-7, 2009. “Citation
    index” 2
44. FENU S, WARDAS J, MORELLI M. Impulse control disorders and dopamine dysregulation syndrome
    associated with dopamine agonist therapy in Parkinson's disease. Behav Pharmacol. 20(5-6):363-
    79, 2009. “Citation index” 3
45. FENU S, CADONI C., G. DI CHIARA (2010). Conditioned saccharin avoidance and sensitization to
    drugs of abuse. Behav Brain Res, 214:248-253.
46. SIMOLA N, PINNA A, FENU S (2010). Pharmacological therapy of Parkinson’s Disease: current
    options and new avenues. Recent Patent on CNS Drug Discovery, 5(3): 221-238.
47. DI CHIARA G, VALENTINI V. FENU S. (2011) Behavioral and neurochemical pharmacology of 5-HT6
    receptors related to reward and reinforcement. International Review of Neurobiology –
    Pharmacology of 5-HT6 Receptors, Part II Volume 96: 111-139.


   H index 19
   Media numero autori 4.28
   I/ultimo nome 17 lavori
   II nome 25 lavori

				
DOCUMENT INFO
Shared By:
Categories:
Tags:
Stats:
views:4
posted:9/3/2011
language:Italian
pages:3